exclusivity extension
AbbVie Extends Rinvoq Exclusivity to 2037, Delaying Generics in U.S.
AbbVie; Rinvoq; patent settlement; generic competition; exclusivity extension; upadacitinib; US market; pharmaceutical litigation
Actionable Insights Powered by AI
AbbVie; Rinvoq; patent settlement; generic competition; exclusivity extension; upadacitinib; US market; pharmaceutical litigation